title: Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P): in von Willebrand disease and haemophilia A.
abstract: Haemate P/Humate-P is a pasteurised human plasma-derived concentrate containing coagulation factor VIII and a near-normal spectrum of von Willebrand factor multimers, including high-molecular weight multimers, for intravenous use in patients with von Willebrand disease or haemophilia A. Extensive clinical experience over the past 25 years has shown that Haemate P/Humate-P provides effective haemostatic control for the prevention and treatment of bleeds in patients with these conditions, with no confirmed cases of viral or prion transmission occurring during this time. In small prospective and retrospective noncomparative studies, Haemate P/Humate-P provided effective haemostatic control for the prevention and treatment of bleeding episodes in the vast majority of paediatric and adult patients with von Willebrand disease. Haemate P/Humate-P was generally well tolerated in patients with von Willebrand disease or haemophilia A.
authors.affiliation: Wolters Kluwer Health, Adis, Auckland, New Zealand. demail@adis.co.nz
authors.forename: Natalie J
authors.initials: NJ
authors.lastname: Carter
authors.forename: Lesley J
authors.initials: LJ
authors.lastname: Scott
mesh_terms: D003029:Coagulants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005169:Factor VIII / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D014842:von Willebrand Diseases / Q000628:therapy*; D014841:von Willebrand Factor / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D003029:Coagulants; D014841:von Willebrand Factor; D005169:Factor VIII